Live Analyst Rating Changes 8035 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Evie Koslosky
GS
Evie Koslosky
Goldman Sachs
Wall Street Analyst
★★★★☆
#734
on 13Foresight · ranked by our own returns
62%
Success Rate
+4.6%
Average Return
10 of 16 calls profitable · +0.5% vs benchmark
🔒 3-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 62% of Evie Koslosky's ratings turned a profit when each position was held for 1 year — averaging +4.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

14 Buy 7 Hold 2 Sell
Evie's Stock Coverage 12 ratings · 2026-07-12
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
GH
Guardant Health
 Jul 09, 2026 BUY Strong Buy
-12.2% avg upside
31 analysts
$165.00
3.06% Upside
 -2.5%
CAI
Caris Life Sciences, Inc.
 Jul 01, 2026 BUY Strong Buy
+65.7% avg upside
20 analysts
$27.00
58.93% Upside
 -9.4%
NTRA
Natera
 Jun 24, 2026 HOLD Strong Buy
-4.0% avg upside
26 analysts
$245.00
9.23% Downside
 +3.8%
SHC
Sotera Health
 Jun 05, 2026 BUY Strong Buy
+11.8% avg upside
13 analysts
$20.00
8.61% Upside
 +17.9%
GRAL
GRAIL Inc
 Jun 05, 2026 HOLD Buy
-8.9% avg upside
8 analysts
$60.00
16.57% Downside
 +20.0%
A
Agilent
 May 27, 2026 BUY Strong Buy
+10.6% avg upside
33 analysts
$155.00
15.45% Upside
 +15.6%
MTD
Mettler-Toledo
 May 08, 2026 HOLD Buy
-9.6% avg upside
18 analysts
$1400.00
8.09% Upside
 +15.2%
WAT
Waters
 May 06, 2026 BUY Strong Buy
+0.2% avg upside
30 analysts
$380.00
0.87% Upside
 +7.7%
RVTY
Revvity
 May 06, 2026 HOLD Buy
-5.5% avg upside
23 analysts
$100.00
10.99% Downside
 +13.3%
DHR
Danaher
 Apr 21, 2026 BUY Strong Buy
+8.5% avg upside
45 analysts
$230.00
15.63% Upside
 +2.5%
BRKR
Bruker
 Feb 13, 2026 SELL Buy
-7.2% avg upside
22 analysts
$35.00
41.76% Downside
 -55.6%
TMO
Thermo Fisher
 Dec 09, 2025 BUY Strong Buy
+11.5% avg upside
38 analysts
$685.00
30.01% Upside
 -6.1%
🔒 7 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Evie Koslosky — Frequently Asked Questions
How accurate are Evie Koslosky's stock ratings?
Based on the calls 13Foresight could measure, about 62% of Evie's ratings were profitable over a one-year hold, with an average return of +4.4% per rating, or +0.3% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Evie ranked on 13Foresight?
Evie Koslosky is currently ranked #734 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Evie cover?
Evie most recently has ratings on GH, CAI, NTRA, SHC, GRAL, A, MTD, WAT, RVTY, DHR, BRKR, TMO. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.